Hanall Biopharma Statistics

Total Valuation

KRX:009420 has a market cap or net worth of KRW 2.59 trillion. The enterprise value is 2.58 trillion.

Market Cap	2.59T
Enterprise Value	2.58T

Important Dates

The last earnings date was Friday, November 14, 2025.

Earnings Date	Nov 14, 2025
Ex-Dividend Date	n/a

Share Statistics

KRX:009420 has 50.78 million shares outstanding. The number of shares has decreased by -1.06% in one year.

Current Share Class	50.78M
Shares Outstanding	50.78M
Shares Change (YoY)	-1.06%
Shares Change (QoQ)	+5.35%
Owned by Insiders (%)	0.40%
Owned by Institutions (%)	13.69%
Float	34.46M

Valuation Ratios

The trailing PE ratio is 1,123.15 and the forward PE ratio is 358.90.

PE Ratio	1,123.15
Forward PE	358.90
PS Ratio	16.84
PB Ratio	16.46
P/TBV Ratio	27.00
P/FCF Ratio	208.07
P/OCF Ratio	187.11
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	1,118.57
EV / Sales	16.78
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	207.22

Financial Position

The company has a current ratio of 2.01, with a Debt / Equity ratio of 0.01.

Current Ratio	2.01
Quick Ratio	0.82
Debt / Equity	0.01
Debt / EBITDA	0.18
Debt / FCF	0.11
Interest Coverage	47.54

Financial Efficiency

Return on equity (ROE) is 1.40% and return on invested capital (ROIC) is 1.45%.

Return on Equity (ROE)	1.40%
Return on Assets (ROA)	1.16%
Return on Invested Capital (ROIC)	1.45%
Return on Capital Employed (ROCE)	2.34%
Revenue Per Employee	506.75M
Profits Per Employee	7.60M
Employee Count	304
Asset Turnover	0.74
Inventory Turnover	1.95

Taxes

In the past 12 months, KRX:009420 has paid 1.08 billion in taxes.

Income Tax	1.08B
Effective Tax Rate	31.79%

Stock Price Statistics

The stock price has increased by +43.14% in the last 52 weeks. The beta is 0.75, so KRX:009420's price volatility has been lower than the market average.

Beta (5Y)	0.75
52-Week Price Change	+43.14%
50-Day Moving Average	39,895.00
200-Day Moving Average	31,864.50
Relative Strength Index (RSI)	58.82
Average Volume (20 Days)	1,128,830

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KRX:009420 had revenue of KRW 154.05 billion and earned 2.31 billion in profits. Earnings per share was 46.29.

Revenue	154.05B
Gross Profit	81.12B
Operating Income	3.84B
Pretax Income	3.39B
Net Income	2.31B
EBITDA	7.42B
EBIT	3.84B
Earnings Per Share (EPS)	46.29

Full Income Statement

Balance Sheet

The company has 11.93 billion in cash and 1.35 billion in debt, giving a net cash position of 10.58 billion or 208.39 per share.

Cash & Cash Equivalents	11.93B
Total Debt	1.35B
Net Cash	10.58B
Net Cash Per Share	208.39
Equity (Book Value)	157.65B
Book Value Per Share	3,104.63
Working Capital	37.81B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 13.87 billion and capital expenditures -1.40 billion, giving a free cash flow of 12.47 billion.

Operating Cash Flow	13.87B
Capital Expenditures	-1.40B
Free Cash Flow	12.47B
FCF Per Share	245.59

Full Cash Flow Statement

Margins

Gross margin is 52.66%, with operating and profit margins of 2.49% and 1.50%.

Gross Margin	52.66%
Operating Margin	2.49%
Pretax Margin	2.20%
Profit Margin	1.50%
EBITDA Margin	4.82%
EBIT Margin	2.49%
FCF Margin	8.10%

Dividends & Yields

KRX:009420 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	1.06%
Shareholder Yield	1.06%
Earnings Yield	0.09%
FCF Yield	0.48%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on April 28, 2006. It was a forward split with a ratio of 10.

Last Split Date	Apr 28, 2006
Split Type	Forward
Split Ratio	10

Scores

KRX:009420 has an Altman Z-Score of 24.05 and a Piotroski F-Score of 6.

Altman Z-Score	24.05
Piotroski F-Score	6